Jim Datin

Jim Datin

Amministratore Delegato presso
BioAgilytix Europe GmbH
63 anni
Health Technology
Finance
Technology Services

Profilo

Mr. Jim A. Datin is an Operating Partner at GHO Capital Partners LLP, a Chief Executive Officer & Director at BALX Holdings LLC and a Co-Managing Director at BioAgilytix Europe GmbH.
He is on the Board of Directors at The North Carolina Biotechnology Center, BALX Holdings LLC, Hepatitis B Foundation and Life Sciences Pennsylvania.
Mr. Datin was previously employed as an Independent Director by OraSure Technologies, Inc., an Independent Director by FSD Pharma, Inc., a Non-Executive Director by BioAgilytix Labs LLC, an Independent Director by NuPathe, Inc., a Vice Chairman by University City Science Center, an Executive Vice President & Managing Director by Safeguard International Management LLC, an EVP & Managing Director-Life Sciences Group by Safeguard Scientifics, Inc., a Chairman by Clarient, Inc., a Chief Executive Officer by TouchPoint Solutions, a Group President by Dendrite International, Inc., a Group Director-Corporate Business Strategy by GlaxoSmithKline, Inc., a Chief Executive Officer by Golden Land Bhd., a Director-International Business by Baxter Corp., a Member by Ben Franklin Technology Partners /Ventures/, a Chairman by Laureate Biopharmaceutical Services, Inc., a Director-International Business by Merck KGaA, and a Group Director by Smithkline Beckman Corp.
He also served on the board at Acelerate, Inc., Celerant Consulting, Inc., Intralinks Holdings, Inc., NovaSom, Inc., Putney, Inc., Rubicor Medical, Inc., Sotera Wireless, Inc. and Ventaira Pharmaceuticals, Inc. He received his undergraduate degree from Marshall University, an undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from the University of New Haven.

Posizioni attive di Jim Datin

SocietàPosizioneInizio
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 01/01/2017
Amministratore Delegato -
Amministratore Delegato -
Investitore di Private Equity 01/01/2023

Precedenti posizioni note di Jim Datin

SocietàPosizioneFine
ORASURE TECHNOLOGIES, INC. Direttore/Membro del Consiglio 01/06/2024
Amministratore Delegato 16/06/2022
QUANTUM BIOPHARMA LTD. Direttore/Membro del Consiglio 30/04/2021
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Jim Datin

Formazione di Jim Datin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

70

Relazioni di 1° grado

34

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private34

Finance

Technology Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Services

Technology Services

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Technology Services

Miscellaneous

Technology Services

Finance

Finance

Commercial Services

Health Technology

Commercial Services

Commercial Services

Consumer Services

Finance

Health Technology

Health Technology

Commercial Services

- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA